LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 196 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $309,786 | -18.5% | 5,170 | -1.9% | 0.07% | -50.7% |
| Q2 2023 | $379,895 | -39.5% | 5,269 | -38.3% | 0.14% | -57.9% |
| Q1 2023 | $627,835 | +95.9% | 8,535 | +77.9% | 0.34% | +113.8% |
| Q4 2022 | $320,440 | -64.4% | 4,797 | -54.1% | 0.16% | -49.5% |
| Q3 2022 | $900,000 | -3.4% | 10,450 | 0.0% | 0.32% | -22.1% |
| Q2 2022 | $932,000 | -20.7% | 10,450 | 0.0% | 0.41% | -26.0% |
| Q1 2022 | $1,176,000 | -27.3% | 10,450 | -0.2% | 0.55% | +103.0% |
| Q4 2021 | $1,618,000 | -0.7% | 10,473 | -10.5% | 0.27% | +105.3% |
| Q3 2021 | $1,630,000 | -9.2% | 11,700 | -14.5% | 0.13% | -41.6% |
| Q2 2021 | $1,796,000 | -27.9% | 13,689 | -16.2% | 0.23% | -45.7% |
| Q1 2021 | $2,490,000 | -68.1% | 16,332 | -79.2% | 0.42% | -47.2% |
| Q4 2020 | $7,805,000 | +97.4% | 78,478 | +89.2% | 0.79% | +109.0% |
| Q3 2020 | $3,954,000 | +64.2% | 41,485 | +92.7% | 0.38% | +140.1% |
| Q2 2020 | $2,408,000 | – | 21,531 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KNOTT DAVID M | 353,041 | $36,819,000 | 14.92% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 919,994 | $95,946,000 | 2.93% |
| Elk Creek Partners, LLC | 236,862 | $24,702,000 | 2.84% |
| Conestoga Capital Advisors, LLC | 619,653 | $64,624,000 | 1.56% |
| WOODSTOCK CORP | 71,489 | $7,456,000 | 1.21% |
| Summit Creek Advisors LLC | 70,962 | $7,401,000 | 1.16% |
| FALCON POINT CAPITAL, LLC | 8,115 | $846,000 | 1.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 302,503 | $31,548,000 | 1.07% |
| Stephens Investment Management Group LLC | 508,100 | $52,990,000 | 1.00% |
| Tygh Capital Management, Inc. | 55,672 | $5,806,000 | 0.96% |